BOOK OF THE WEEK:
This is one of the very few books written for people with dementia. It is designed to ease a person along the pathway of forgetfulness. Read these reviews to see how.
BOOK OF THE WEEK:
This is one of the very few books written for people with dementia. It is designed to ease a person along the pathway of forgetfulness. Read these reviews to see how.






This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To

Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.

GENETICS & LIFESTYLE VIDEO: How do family history and genetics affect a healthy person’s risk of Alzheimer’s? Watch Harvard’s Top Alzheimer’s researcher, Dr. Rudy Tanzi, offer down-to-Earth insights.

A Quest Diagnostics amyloid beta blood test introduced to the market in 2022 helps determine the Alzheimer’s risk for people with signs of mild cognitive impairment or dementia.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On